“Optimal” Dose Finding Could Result In More Late-Stage Drug Success

A paradigm shift from maximum-tolerated dose to effective dose would result in more successful late-stage drug development, FDA Office of Clinical Pharmacology & Biopharmaceutics Pharmacometrics Team Leader Joga Gobburu, PhD, said April 23